A new study suggests that certain sexually trasmitted infections, such as herpes simplex virus 2, may have a role in the development of certain types of ovarian cancer.
Across different drugs and clinical settings, use of PARPi has resulted in a prolonged period without cancer recurrence.
Results of new research led by Australian investigators suggest that interleukin-6 (IL-6) may have a role in diagnosis of ovarian cancer—but not on its own.
Experience in more than a quarter million women shows no significant association between use of powder in the genital area and ovarian cancer.
September is Ovarian Cancer Awareness month. In this month's poll, we want to know if you discuss salpingectomy as a prophylactic measure against ovarian cancer with your patients.
Ilana Cass, MD, discusses whether salpingectomy should be part of every routine tubal sterilization.
Three tests are now FDA-approved for triaging pelvic masses in asymptomatic women.